Cargando…
Hepatic Hippo signaling inhibits development of hepatocellular carcinoma
Primary liver cancer is one of the most common cancer worldwide. Hepatocellular carcinoma (HCC) in particular, is the second leading cause of cancer deaths in the world. The Hippo signaling pathway has emerged as a major oncosuppressive pathway that plays critical roles inhibiting hepatocyte prolife...
Autores principales: | Liu, Yuchen, Wang, Xiaohui, Yang, Yingzi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641559/ https://www.ncbi.nlm.nih.gov/pubmed/32981290 http://dx.doi.org/10.3350/cmh.2020.0178 |
Ejemplares similares
-
ACTN1 supports tumor growth by inhibiting Hippo signaling in hepatocellular carcinoma
por: Chen, Qian, et al.
Publicado: (2021) -
KCTD11 inhibits growth and metastasis of hepatocellular carcinoma through activating Hippo signaling
por: Tong, Rongliang, et al.
Publicado: (2017) -
High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
por: Moon, Hyuk, et al.
Publicado: (2019) -
Correction to: ACTN1 supports tumor growth by inhibiting Hippo signaling in hepatocellular carcinoma
por: Chen, Qian, et al.
Publicado: (2021) -
α-Hederin Inhibits the Proliferation of Hepatocellular Carcinoma Cells via Hippo-Yes-Associated Protein Signaling Pathway
por: Chen, Tongqing, et al.
Publicado: (2022)